Reply: Promise and Limitations of Relaxin-based Therapies in Chronic Fibrotic Lung Diseases

Am J Respir Crit Care Med. 2016 Dec 1;194(11):1435-1436. doi: 10.1164/rccm.201607-1464LE.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Lung Diseases*
  • Relaxin*

Substances

  • Relaxin